These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Survivor treatment selection bias and outcomes research: a case study of surgery in infective endocarditis. Sy RW, Bannon PG, Bayfield MS, Brown C, Kritharides L. Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):469-74. PubMed ID: 20031879 [Abstract] [Full Text] [Related]
5. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, Fowler VG, Gordon D, Grossi P, Hannan M, Hoen B, Muñoz P, Rizk H, Kanj SS, Selton-Suty C, Sexton DJ, Spelman D, Ravasio V, Tripodi MF, Wang A, International Collaboration on Endocarditis–Prospective Cohort Study Investigators. JAMA Intern Med; 2013 Sep 09; 173(16):1495-504. PubMed ID: 23857547 [Abstract] [Full Text] [Related]
6. Early outcome after surgery for active native and prosthetic aortic valve endocarditis. Gabbieri D, Dohmen PM, Linneweber J, Grubitzsch H, von Heymann C, Neumann K, Halle E, Konertz WF. J Heart Valve Dis; 2008 Sep 09; 17(5):508-24; discussion 525. PubMed ID: 18980085 [Abstract] [Full Text] [Related]
7. Native versus primary prosthetic valve endocarditis: comparison of clinical features and long-term outcome in 353 patients. Romano G, Carozza A, Della Corte A, De Santo LS, Amarelli C, Torella M, De Feo M, Cerasuolo F, Cotrufo M. J Heart Valve Dis; 2004 Mar 09; 13(2):200-8; discussion 208-9. PubMed ID: 15086258 [Abstract] [Full Text] [Related]
8. Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Montori VM, Hoskin TL, Enders F, Huskins WC, Mookadam F, Wilson WR, Zimmerman V, Baddour LM. J Clin Epidemiol; 2010 Feb 09; 63(2):130-5. PubMed ID: 20122499 [Abstract] [Full Text] [Related]
9. Surgical treatment of active aortic endocarditis: homografts are not the cornerstone of outcome. Avierinos JF, Thuny F, Chalvignac V, Giorgi R, Tafanelli L, Casalta JP, Raoult D, Mesana T, Collart F, Metras D, Habib G, Riberi A. Ann Thorac Surg; 2007 Dec 09; 84(6):1935-42. PubMed ID: 18036910 [Abstract] [Full Text] [Related]
10. Impact of early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis. Funakoshi S, Kaji S, Yamamuro A, Tani T, Kinoshita M, Okada Y, Furukawa Y. J Thorac Cardiovasc Surg; 2011 Oct 09; 142(4):836-842.e1. PubMed ID: 21397271 [Abstract] [Full Text] [Related]
11. Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment. Siniawski H, Grauhan O, Hofmann M, Pasic M, Weng Y, Yankah C, Lehmkuhl H, Hetzer R. Eur J Cardiothorac Surg; 2005 Mar 09; 27(3):434-40. PubMed ID: 15740952 [Abstract] [Full Text] [Related]
12. Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes. Murashita T, Sugiki H, Kamikubo Y, Yasuda K. Eur J Cardiothorac Surg; 2004 Dec 09; 26(6):1104-11. PubMed ID: 15541970 [Abstract] [Full Text] [Related]
13. Outcome of patients requiring valve surgery during active infective endocarditis. Hill EE, Herregods MC, Vanderschueren S, Claus P, Peetermans WE, Herijgers P. Ann Thorac Surg; 2008 May 09; 85(5):1564-9. PubMed ID: 18442538 [Abstract] [Full Text] [Related]
14. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. Carozza A, De Santo LS, Romano G, Della Corte A, Ursomando F, Scardone M, Caianiello G, Cotrufo M. J Heart Valve Dis; 2006 Jan 09; 15(1):125-31. PubMed ID: 16480024 [Abstract] [Full Text] [Related]
15. Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience. Musci M, Siniawski H, Pasic M, Grauhan O, Weng Y, Meyer R, Yankah CA, Hetzer R. Eur J Cardiothorac Surg; 2007 Jul 09; 32(1):118-25. PubMed ID: 17412606 [Abstract] [Full Text] [Related]
16. Infective endocarditis in patients with end-stage renal disease: clinical presentation and outcome. Spies C, Madison JR, Schatz IJ. Arch Intern Med; 2004 Jan 12; 164(1):71-5. PubMed ID: 14718325 [Abstract] [Full Text] [Related]
17. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. J Am Coll Cardiol; 2005 Feb 01; 45(3):381-7. PubMed ID: 15680716 [Abstract] [Full Text] [Related]
18. Mitral valve repair provides improved outcome over replacement in active infective endocarditis. Ruttmann E, Legit C, Poelzl G, Mueller S, Chevtchik O, Cottogni M, Ulmer H, Pachinger O, Laufer G, Mueller LC. J Thorac Cardiovasc Surg; 2005 Sep 01; 130(3):765-71. PubMed ID: 16153926 [Abstract] [Full Text] [Related]
19. Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction. Halkos ME, Chen EP, Sarin EL, Kilgo P, Thourani VH, Lattouf OM, Vega JD, Morris CD, Vassiliades T, Cooper WA, Guyton RA, Puskas JD. Ann Thorac Surg; 2009 Sep 01; 88(3):746-51. PubMed ID: 19699891 [Abstract] [Full Text] [Related]
20. Surgical treatment of infective mitral valve endocarditis. Wilhelm MJ, Tavakoli R, Schneeberger K, Hörstrupp S, Reuthebuch O, Seifert B, Turinal M, Genoni M. J Heart Valve Dis; 2004 Sep 01; 13(5):754-9. PubMed ID: 15473475 [Abstract] [Full Text] [Related] Page: [Next] [New Search]